Italy Country Drug Report 2018

Drug-related research

Drug-related research, covering a wide range of topics (including prevalence and patterns of substance use and related risk behaviours, prevention and other interventions, new psychoactive substances, law enforcement and policy evaluation) is explored in Italy by a network of researchers and institutions. Various research groups, coordinated by the Department for Anti-Drug Policies (DAP), collaborate to draft an annual report to the Italian parliament. Public organisations, such as the National Research Council, the National Statistical Office and the National Health Institute, as well as several ministries and partners from the private sector, usually implement studies for the report.

The Italian Action Plan recognises the importance of drug-related research, especially in the fields of neuroscience, neuroimaging, and behavioural, social and educational sciences. Additionally, the DAP has agreed with the Italian Ministry of Education and Research to strengthen policies to prevent substance use, particularly geared towards school-aged children.

Research priorities in Italy include (i) improving the strategies for diagnosis/early detection to reduce the gap between first drug use and first access to treatment; (ii) prioritising neuroscience and neuroimaging research to study brain damage related to drug use and the mechanisms of craving and self-control; and (iii) promoting new pharmacological treatments and vaccines and, at the same time, residential treatments and mental rehabilitation. The strategy for new psychoactive substances promotes diagnostic, clinical, toxicological and neuroscience research, as well as research on new online illegal marketing methods and prevention.


Italy main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.